Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

Nicole Skoetz; Marius Goldkuhle; Gerald Gartlehner; Ina Monsef; Philipp Dahm; Jan Peter Glossmann; Andreas Engert; Bastian von Tresckow

doi:10.1002/14651858.CD012556

Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

Nicole Skoetz
, Marius Goldkuhle
, Gerald Gartlehner
, Ina Monsef
, Philipp Dahm
, Jan Peter Glossmann
, Andreas Engert
, Bastian von Tresckow

Urology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of nivolumab in adult individuals with Hodgkin lymphoma (HL).

Original language	English (US)
Article number	CD012556
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	2
DOIs	https://doi.org/10.1002/14651858.CD012556
State	Published - Feb 17 2017

Bibliographical note

Publisher Copyright:
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1002/14651858.CD012556

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464616

Find It

Find It at U of M Libraries

Cite this

@article{974ba33ada844e0c9ef7b3f1e9277052,

title = "Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of nivolumab in adult individuals with Hodgkin lymphoma (HL).",

author = "Nicole Skoetz and Marius Goldkuhle and Gerald Gartlehner and Ina Monsef and Philipp Dahm and Glossmann, \{Jan Peter\} and Andreas Engert and \{von Tresckow\}, Bastian",

note = "Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2017",

month = feb,

day = "17",

doi = "10.1002/14651858.CD012556",

language = "English (US)",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

TY - JOUR

T1 - Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

AU - Skoetz, Nicole

AU - Goldkuhle, Marius

AU - Gartlehner, Gerald

AU - Monsef, Ina

AU - Dahm, Philipp

AU - Glossmann, Jan Peter

AU - Engert, Andreas

AU - von Tresckow, Bastian

PY - 2017/2/17

Y1 - 2017/2/17

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of nivolumab in adult individuals with Hodgkin lymphoma (HL).

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of nivolumab in adult individuals with Hodgkin lymphoma (HL).

UR - https://www.scopus.com/pages/publications/85013074515

UR - https://www.scopus.com/pages/publications/85013074515#tab=citedBy

U2 - 10.1002/14651858.CD012556

DO - 10.1002/14651858.CD012556

M3 - Article

AN - SCOPUS:85013074515

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD012556

ER -

Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this